http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#head http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#assertion http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#provenance http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#publicationInfo http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#assertion http://bio2rdf.org/drugbank:DB00248 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00248_DB00315 http://bio2rdf.org/drugbank:DB00315 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00248_DB00315 http://bio2rdf.org/drugbank_resource:DB00248_DB00315 http://purl.org/dc/terms/identifier drugbank_resource:DB00248_DB00315 http://bio2rdf.org/drugbank_resource:DB00248_DB00315 http://purl.org/dc/terms/title DDI between Cabergoline and Zolmitriptan - Concomitant use of the serotonin 5-HT1D receptor agonist, zolmitriptan, and the ergot derivative, carbergoline, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. Use of two serotonin modulators, such as zolmitriptan and carbergoline, increases the risk of serotonin syndrome. Consider alternate therapy or monitor for serotonin syndrome during concomitant therapy. http://bio2rdf.org/drugbank_resource:DB00248_DB00315 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00248_DB00315 http://www.w3.org/2000/01/rdf-schema#label DDI between Cabergoline and Zolmitriptan - Concomitant use of the serotonin 5-HT1D receptor agonist, zolmitriptan, and the ergot derivative, carbergoline, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. Use of two serotonin modulators, such as zolmitriptan and carbergoline, increases the risk of serotonin syndrome. Consider alternate therapy or monitor for serotonin syndrome during concomitant therapy. [drugbank_resource:DB00248_DB00315] http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#provenance http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#publicationInfo http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#signature.MCwCFESTrsKyih1h http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#signature.MCwCFESTrsKyih1h http://purl.org/nanopub/x/hasSignature MCwCFESTrsKyih1hFtJH4rpZhK+IIL5KAhRBSnOoK3Y4uT/Q4gCrz6F+/z255g== http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#signature.MCwCFESTrsKyih1h http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50 http://purl.org/dc/terms/created 2018-03-30T11:13:01.731+02:00 http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50#signature.MCwCFESTrsKyih1h http://bio2rdf.org/drugbank_resource:DB00248_DB00315_nanopub.RAjdJ7VPLqNnYVqTzeOFomwyRKGUjnZx1A0HbIpEV5d50 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234